Hwa-Jun Lee

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Samsung Electronics Co., Ltd., Viromed Co., Ltd.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hwa-Jun Lee. Retrieved from https://idiyas.com/inventor/hwa-jun-lee-dlzq6sd7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 75.0

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Suwon-si, KR (2013)
Gyeonggi-do, KR (2017)
Seongnam-si, KR (2017 - 2021)

Company Filing History:

3 out of 132,108

Samsung Electronics Co., Ltd.

Years Active: 2013-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10922857 - Electronic device and operation method for performing a drawing function (2021-02-16),

2. 9792183 - Method, apparatus, and recording medium for interworking with external terminal (2017-10-17),

3. 9754553 - Electronic device and method of controlling a screen of an external electronic device (2017-09-05),

4. 8394426 - Composition comprising an extract of hardy kiwi for preventing or treating baldness disorders or seborrheic skin disorders (2013-03-12),

Title: Hwa-Jun Lee: Innovator in Pharmaceutical Composition

Introduction

Hwa-Jun Lee is a notable inventor based in South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment and prevention of allergic diseases and non-allergic inflammatory diseases. His innovative work focuses on utilizing natural extracts for health benefits.

Latest Patents

Hwa-Jun Lee holds a patent for a composition comprising the extract of Actinidia arguta and related species. This invention provides a pharmaceutical composition that effectively treats and prevents allergic diseases and non-allergic inflammatory diseases. The active ingredient, derived from hardy kiwifruit, works by reducing inflammation, inhibiting histamine release from mast cells, and modulating cytokine levels in serum.

Career Highlights

Hwa-Jun Lee is associated with Helixir Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical sector. His work emphasizes the importance of natural ingredients in medical applications, showcasing his commitment to advancing health science.

Collaborations

Hwa-Jun Lee collaborates with colleagues such as Bongcheol Kim and Mirim Jin. Their combined efforts contribute to the ongoing research and development of effective health solutions.

Conclusion

Hwa-Jun Lee's contributions to the field of pharmaceutical compositions highlight the potential of natural extracts in treating various health conditions. His innovative approach continues to inspire advancements in medical research and applications.

Profile summary based on public USPTO records.